KETOFEN® 10% - new claim for lameness

Merial Animal Health has received approval for the addition of an indication for reducing pain associated with lameness in cattle for its KETOFEN® 10% Solution for Injection. The product, which contains 100 mg/ml of ketoprofen, is already approved for reducing pyrexia associated with pneumonia, acute clinical mastitis and acute endotoxin mastitis, downer cows and reducing oedema of the udder, and provides rapid relief from inflammation and pain.

KETOFEN® 10% is of particular benefit when treating dairy cows as it has a zero milk withhold.

Merial Animal Health's Product Manager Victoria Hudson said: "KETOFEN® 10% has an excellent track record in providing rapid pain relief and helping cattle to quickly return to productivity 12 3. We are pleased to be able to add the treatment of pain associated with lameness to the list of indications."

KETOFEN® 10% is licensed for both intramuscular and intravenous administration, and works rapidly reaching peak plasma levels within 40 minutes following intramuscular administration4. Unlike some other non-steroidal anti-inflammatory drugs, repeat doses of KETOFEN® 10% can be given over a three day period in cattle if required.

Click here to read the product SPC 

Click here to go to the product page


12th August 2014

Back to news